Efficacy of cariprazine on predominant negative symptoms of patients with schizophrenia: post hoc analysis of PANSS data, Marder factors, and cognition

被引：7

作者：

Marder, S. ^{[1
]}

Laszlovszky, I. ^{[2
]}

Szalai, E. ^{[2
]}

Szatmari, B. ^{[2
]}

Harsanyi, J. ^{[2
]}

Barabassy, A. ^{[2
]}

Debelle, M. ^{[2
]}

Durgam, S. ^{[3
]}

Bitter, I. ^{[4
]}

Nemeth, G. ^{[2
]}

机构：

[1] Univ Calif Los Angeles, Semel Inst, Sect Psychosis, Los Angeles, CA USA

[2] Gedeon Richter Plc, Med Div, Budapest, Hungary

[3] Forest Res Inst, Clin Dev, Jersey City, NJ USA

[4] Semmelweis Univ, Dept Psychiat & Psychotherapy, Budapest, Hungary

来源：

EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2016年 / 26卷

关键词：

D O I：

10.1016/S0924-977X(16)31595-4

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P.3.d.036

引用

页码：S550 / S550

页数：1

共 50 条

[41] BAYESIAN ESTIMATION OF THE TRANSITION PROBABILITY MATRIX IN MARKOV MODELLING WITH INFORMATIVE PRIOR: AN EXAMPLE FROM THE ANALYSIS OF THE TREATMENT OF PATIENTS WITH PREDOMINANT NEGATIVE SYMPTOMS OF SCHIZOPHRENIA WITH CARIPRAZINE [J].

Voko, Z. ;

Bitter, I ;

Merisch, B. ;

Rethelyi, J. ;

Molnar, A. ;

Pitter, J. G. ;

Gotze, A. ;

Ruzsa, V ;

Koczian, K. ;

Fonticoli, L. ;

Lelli, F. ;

Nemeth, B. .

VALUE IN HEALTH, 2019, 22 :S814-S815

[42] What is the minimally clinically important difference in negative symptoms of schizophrenia? PANSS based post hoc analyses of a phase III clinical trial [J].

Barabassy, A. ;

Acsai, K. ;

Laszlovszky, I. ;

Szatmari, B. ;

Harsanyi, J. ;

Sebe, B. ;

Earley, W. ;

Patel, M. ;

Nemeth, G. .

EUROPEAN PSYCHIATRY, 2019, 56 :S247-S247

[43] Efficacy of Lurasidone in the Treatment of Schizophrenia with Prominent Negative Symptoms: A Post-hoc Analysis of Short-term Trials [J].

Schooler, Nina R. ;

Pikalov, Andrei ;

Hsu, Jay ;

Cucchiaro, Josephine ;

Goldman, Robert ;

Loebel, Antony .

NEUROPSYCHOPHARMACOLOGY, 2013, 38 :S513-S514

[44] EFFICACY OF LURASIDONE IN THE TREATMENT OF SCHIZOPHRENIA WITH PROMINENT NEGATIVE SYMPTOMS: A POST-HOC ANALYSIS OF SHORT-TERM TRIALS [J].

Pikalov, Andrei ;

Schooler, Nina ;

Hsu, Jay ;

Cucchiaro, Josephine ;

Goldman, Robert ;

Loebel, Antony .

SCHIZOPHRENIA RESEARCH, 2014, 153 :S355-S355

[45] Efficacy of lurasidone in the treatment of schizophrenia with prominent negative symptoms: A post-hoc analysis of short-term trials [J].

Schooler, N. R. ;

Pikalov, A. ;

Hsu, J. ;

Cucchiaro, J. ;

Goldman, R. ;

Loebel, A. .

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 :151-152

[46] The broad efficacy of cariprazine across symptoms in patients with bipolar I disorder: Post hoc analysis of randomized, placebo-controlled trials [J].

Yatham, Lakshmi ;

Vieta, Eduard ;

McIntyre, Roger ;

Jain, Rakesh ;

Earley, Willie ;

Patel, Mehul .

BIPOLAR DISORDERS, 2020, 22 :114-114

[47] The Effect of Instability of Baseline Severity of Positive Symptoms on End of Treatment Change in the PANSS Negative Factor Score in Negative Symptom Schizophrenia Studies - An Exploratory Post-Hoc Analysis [J].

Daniel, David ;

Wang, Xingmei ;

Kott, Alan .

NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) :371-371

[48] Efficacy of Adjunctive Cariprazine on Anxiety Symptoms in Patients With Major Depressive Disorder: Post Hoc Analysis of a Randomized Placebo-Controlled Trial [J].

Fava, Maurizio ;

Masand, Prakash S. ;

Maletic, Vladimir ;

Chen, Chen ;

Adams, Julie L. ;

Kerolous, Majid .

JOURNAL OF CLINICAL PSYCHIATRY, 2025, 86 (02)

[49] Day-to-day and social functioning of patients with negative symptoms of schizophrenia: Post-hoc analyses of a phase 3 clinical trial with cariprazine monotherapy and risperidone [J].

Barabassy, A. ;

Laszlovszky, I. ;

Szatmari, B. ;

Szalai, E. ;

Harsanyi, J. ;

Nemeth, G. .

EUROPEAN PSYCHIATRY, 2017, 41 :S270-S270

[50] Monotherapy treatment with cariprazine for the treatment of predominant negative symptoms of patients with schizophrenia: A double-blind, active comparator-controlled trial [J].

Nemeth, G. ;

Debelle, M. ;

Laszlovszky, I. ;

Szalai, E. ;

Szatmari, B. ;

Harsanyi, J. ;

Barabassy, A. ;

Durgam, S. ;

Bitter, I. ;

Galderisi, S. .

EUROPEAN PSYCHIATRY, 2016, 33 :S256-S257

← 1 2 3 4 5 →